The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
Open accessAbstract
BACKGROUND: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. METHODS: We used population-level longitudinal data from province-wide registries including plasma viral load, CD4 count, drug resistance, HAART use, HIV diagnoses, AIDS incidence, and HIV-related mortality. We fitted two Poisson regression models over the study period, to relate estimated HIV incidence and the number of individuals on HAART and the percentage of virologically suppressed individuals. RESULTS: HAART coverage, median pre-HAART CD4 count, and HAART adherence increased over time and were associated with increasing virological suppression and decreasing drug resistance. AIDS incidence decreased from 6.9 to 1.4 per 100,000 population (80% decrease, p = 0.0330) and HIV-related mortality decreased from 6.5 to 1.3 per 100,000 population (80% decrease, p = 0.0115). New HIV diagnoses declined from 702 to 238 cases (66% decrease; p = 0.0004) with a consequent estimated decline in HIV incident cases from 632 to 368 cases per year (42% decrease; p = 0.0003). Finally, our models suggested that for each increase of 100 individuals on HAART, the estimated HIV incidence decreased 1.2% and for every 1% increase in the number of individuals suppressed on HAART, the estimated HIV incidence also decreased by 1%. CONCLUSIONS: Our results show that HAART expansion between 1996 and 2012 in BC was associated with a sustained and profound population-level decrease in morbidity, mortality and HIV transmission. Our findings support the long-term effectiveness and sustainability of HIV treatment as prevention within an adequately resourced environment with no financial barriers to diagnosis, medical care or antiretroviral drugs. The 2013 Consolidated World Health Organization Antiretroviral Therapy Guidelines offer a unique opportunity to further evaluate TasP in other settings, particularly within generalized epidemics, and resource-limited setting, as advocated by UNAIDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Generalized Additive Models: An Introduction with R
Wood, S. N. (2017) · doi:10.1201/9781315370279 · Cited by 13,852
Brown, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Biometrics · doi:10.2307/2532174 · Cited by 8,176
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ: Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
Hastie, T., & Tibshirani, R. (2014) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat03141 · Cited by 3,156
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1
&NA; (2001) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200106000-00020 · Cited by 1,660
Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., McIntyre, J., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 952
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M.-L. (2013) · Science · doi:10.1126/science.1228160 · Cited by 796
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780
Self-citationDas, M., Chu, P. L., Santos, G.-M., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011068 · Cited by 771
Behavioural strategies to reduce HIV transmission: how to make them work better
Coates, T. J., Richter, L., & Caceres, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60886-7 · Cited by 760
Per-Contact Risk of Human Immunodificiency Virus Tramnsmision between Male Sexual Partners
Vitinghoff, E., Douglas, J., Judon, F., McKiman, D., MacQueen, K., & Buchinder, S. P. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010003 · Cited by 594
Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., & Harrigan, P. R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69162-9 · Cited by 555
Self-citationCarpenter, C. C. J. (1996) · JAMA · doi:10.1001/jama.276.2.146 · Cited by 541
Antiretroviral Therapy for HIV Infection: A Knowledge-Based Approach to Drug Selection and Use
Moyle, G. J., Gazzard, B. G., Cooper, D. A., & Gatell, J. (1998) · Drugs · doi:10.2165/00003495-199855030-00005 · Cited by 536
Wood, E., Kerr, T., Marshall, B. D. L., Li, K., Zhang, R., Hogg, R. S., Harrigan, P. R., & Montaner, J. S. G. (2009) · BMJ · doi:10.1136/bmj.b1649 · Cited by 342
Self-citationVIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
Uinn, T. H. C. Q., Awer, M. A. J. W., Ewankambo, N. E. S., Erwadda, D. A. S., Eehan, M. A. O. M., Utalo, T. H. L., Onald, R., Ray, H. G., Roject, A. P., & Roup, S. T. G. (2011) · Cited by 305
Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART
Jin, F., Jansson, J., Law, M., Prestage, G. P., Zablotska, I., Imrie, J. C., Kippax, S. C., Kaldor, J. M., Grulich, A. E., & Wilson, D. P. (2010) · AIDS · doi:10.1097/qad.0b013e3283372d90 · Cited by 265
Rotheram-Borus, M. J., Swendeman, D., & Chovnick, G. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153530 · Cited by 246
Fang, C., Hsu, H., Twu, S., Chen, M., Chang, Y., Hwang, J., Wang, J., Chuang, C., & Division of AIDS and STD, C. F. D. C. (2004) · The Journal of Infectious Diseases · doi:10.1086/422601 · Cited by 243
Update of the drug resistance mutations in HIV-1: March 2013.
Johnson, V. A., Cálvez, V., Günthard, H. F., Paredes, R., Pillay, D., Shafer, R. W., Wensing, A. M. J., & Richman, D. D. (2013) · Europe PMC (PubMed Central) · Cited by 240
Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART
Stolte, I. G. (2001) · Sexually Transmitted Infections · doi:10.1136/sti.77.3.184 · Cited by 192
Granich, R., Kahn, J. G., Bennett, R., Holmes, C. B., Garg, N., Serenata, C., Sabin, M. L., Makhlouf-Obermeyer, C., De Filippo Mack, C., Williams, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030216 · Cited by 175
Lima, V. D., Harrigan, R., Murray, M., Moore, D. M., Wood, E., Hogg, R. S., & Montaner, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e328315cdd3 · Cited by 166
Self-citationThe new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis
Cremin, Í., Alsallaq, R. A., Dybul, M. R., Piot, P. K., Garnett, G. P., & Hallett, T. B. (2012) · AIDS · doi:10.1097/qad.0b013e32835ca2dd · Cited by 155
Hontelez, J. A. C., Lurie, M. N., Bärnighausen, T., Bakker, R., Baltussen, R. M. P. M., Tanser, F. C., Hallett, T. B., Newell, M., & de Vlas, S. J. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001534 · Cited by 147
Treatment as prevention—a double hat-trick
Montaner, J. S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60821-0 · Cited by 146
Self-citationCost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples
Walensky, R. P., Ross, E. L., Kumarasamy, N., Wood, R., Noubary, F., Paltiel, A. D., Nakamura, Y., Godbole, S., Panchia, R., Sanne, I., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1214720 · Cited by 140
Hull, M., Wu, Z., & Montaner, J. S. G. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283590617 · Cited by 101
Self-citationAvettand-Fènoël, V., Prazuck, T., Hocqueloux, L., Mélard, A., Michau, C., Kerdraon, R., Agoute, E., & Rouzioux, C. (2008) · AIDS · doi:10.1097/qad.0b013e32830fbdbc · Cited by 71
Kato, M., Granich, R., Bui, D. D., Tran, H. V., Nadol, P., Jacka, D., Sabin, K. M., Suthar, A. B., Mesquita, F., Lo, Y. R., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829b535b · Cited by 70
Zuckerman, R. A., Whittington, W. L. H., Celum, C., Collis, T., Lucchetti, A., Sanchez, J. L., Hughes, J. P., Sánchez, J. L., & Coombs, R. W. (2004) · The Journal of Infectious Diseases · doi:10.1086/421246 · Cited by 69
Does ART prevent HIV transmission among MSM?
Muessig, K. E., Smith, M. K., Powers, K. A., Lo, Y. R., Burns, D., Grulich, A. E., Phillips, A. N., & Cohen, M. S. (2012) · AIDS · doi:10.1097/qad.0b013e328355713d · Cited by 64
Wagner, B. G., & Blower, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041212 · Cited by 57
McCormick, A. W., Walensky, R. P., Lipsitch, M., Losina, E., Hsu, H., Weinstein, M. C., Paltiel, A. D., Freedberg, K. A., & Seage, G. R. (2007) · Clinical Infectious Diseases · doi:10.1086/512816 · Cited by 52
Disparities in the Burden of HIV/AIDS in Canada
Hogg, R. S., Heath, K., Lima, V. D., Nosyk, B., Kanters, S., Wood, E., Kerr, T. H., & Montaner, J. S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047260 · Cited by 41
Self-citationTranslation of Biomedical Prevention Strategies for HIV: Prospects and Pitfalls
Vermund, S. H., Tique, J. A., Cassell, H. M., Pask, M. E., Ciampa, P. J., & Audet, C. M. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829202a2 · Cited by 39
Antiretroviral-Based HIV-1 Prevention: Antiretroviral Treatment and Pre-Exposure Prophylaxis
Celum, C., & Baeten, J. M. (2012) · Antiviral Therapy · doi:10.3851/imp2492 · Cited by 37
HIV-prevention science at a crossroads: advances in reducing sexual risk
Vermund, S. H., Allen, K. L., & Karim, Q. A. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832c91dd · Cited by 33
Wand, H. C., Wilson, D. P., Yan, P., Gonnermann, A., McDonald, A., Kaldor, J. M., & Law, M. G. (2009) · Journal of the International AIDS Society · doi:10.1186/1758-2652-12-19 · Cited by 29
Treatment as prevention: translating efficacy trial results to population effectiveness
Garnett, G. P., Becker, S. L., & Bertozzi, S. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283504ab7 · Cited by 22
Infectiousness of HIV-infected homosexual men in the era of highly active antiretroviral therapy
Baggaley, R. F., White, R. G., & Boily, M. (2010) · AIDS · doi:10.1097/qad.0b013e32833dbdfd · Cited by 21
Cited by
Saul, J., Bachman, G., Allen, S., Toiv, N. F., Cooney, C., & Beamon, T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0208167 · Cited by 319
Leddy, A. M., Weiss, E., Yam, E., & Pulerwitz, J. (2019) · BMC Public Health · doi:10.1186/s12889-019-7192-4 · Cited by 140
Cheah, M. H., Gan, Y. N., Altice, F. L., Wickersham, J. A., Shrestha, R., Salleh, N. A. M., Ng, K. S., Azwa, I., Balakrishnan, V., Kamarulzaman, A., et al. (2024) · JMIR Human Factors · doi:10.2196/52055 · Cited by 53
“HIV testing is a prerequisite to effective HIV prevention and early treatment initiation [6]; people at risk for HIV or seropositive individuals need to be tested for HIV before being linked to health care services [7].”
Background
Metadata
- Authors
- Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., Wood, E., Kerr, T., Shannon, K., Moore, D., Hogg, R. S., Barrios, R., Gilbert, M., Krajden, M., Gustafson, R., Daly, P., & Kendall, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-12
- Volume
- 9
- Issue
- 2
- Pages
- e87872
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2062290173
- Cited by
- 354
- References
- 48
- FWCI
- 28.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.